Skip to main content
. 2003 Jul 21;2003(3):CD003066. doi: 10.1002/14651858.CD003066

Comparison 1. Treatment studies: CSF versus control.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 All cause mortality to 14 days 7 257 Risk Ratio (M‐H, Fixed, 95% CI) 0.71 [0.38, 1.33]
1.1 G‐CSF 6 197 Risk Ratio (M‐H, Fixed, 95% CI) 1.09 [0.52, 2.29]
1.2 GM‐CSF 1 60 Risk Ratio (M‐H, Fixed, 95% CI) 0.22 [0.05, 0.94]
2 All cause mortality to 28 days 5 194 Risk Ratio (M‐H, Fixed, 95% CI) 0.51 [0.27, 0.98]
2.1 G‐CSF 4 134 Risk Ratio (M‐H, Fixed, 95% CI) 0.63 [0.29, 1.39]
2.2 GM‐CSF 1 60 Risk Ratio (M‐H, Fixed, 95% CI) 0.33 [0.10, 1.11]
3 All cause mortality to discharge 5 178 Risk Ratio (M‐H, Fixed, 95% CI) 0.53 [0.25, 1.16]
3.1 G‐CSF 4 118 Risk Ratio (M‐H, Fixed, 95% CI) 0.78 [0.27, 2.21]
3.2 GM‐CSF 1 60 Risk Ratio (M‐H, Fixed, 95% CI) 0.33 [0.10, 1.11]
4 Failure to correct neutropenia in those neutropenic at trial entry 3 88 Risk Ratio (M‐H, Fixed, 95% CI) 0.13 [0.04, 0.46]
4.1 G‐CSF 2 28 Risk Ratio (M‐H, Fixed, 95% CI) 0.42 [0.07, 2.46]
4.2 GM‐CSF 1 60 Risk Ratio (M‐H, Fixed, 95% CI) 0.06 [0.01, 0.44]
5 All cause mortality to 14 days, in those neutropenic at trial entry 3 97 Risk Ratio (M‐H, Fixed, 95% CI) 0.34 [0.12, 0.92]
5.1 G‐CSF 2 37 Risk Ratio (M‐H, Fixed, 95% CI) 0.58 [0.14, 2.43]
5.2 GM‐CSF 1 60 Risk Ratio (M‐H, Fixed, 95% CI) 0.22 [0.05, 0.94]
6 All cause mortality to 28 days, in those neutropenic at trial entry 3 97 Risk Ratio (M‐H, Fixed, 95% CI) 0.38 [0.16, 0.95]
6.1 G‐CSF 2 37 Risk Ratio (M‐H, Fixed, 95% CI) 0.47 [0.12, 1.83]
6.2 GM‐CSF 1 60 Risk Ratio (M‐H, Fixed, 95% CI) 0.33 [0.10, 1.11]
7 All cause mortality to discharge, in those neutropenic at trial entry 3 97 Risk Ratio (M‐H, Fixed, 95% CI) 0.38 [0.16, 0.95]
7.1 G‐CSF 2 37 Risk Ratio (M‐H, Fixed, 95% CI) 0.47 [0.12, 1.83]
7.2 GM‐CSF 1 60 Risk Ratio (M‐H, Fixed, 95% CI) 0.33 [0.10, 1.11]
8 All cause mortality to 14 days, in those without known neutropenia at trial entry 4 132 Risk Ratio (M‐H, Fixed, 95% CI) 1.22 [0.50, 2.99]
8.1 G‐CSF 4 132 Risk Ratio (M‐H, Fixed, 95% CI) 1.22 [0.50, 2.99]
8.2 GM‐CSF 0 0 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]